Baldrige Asset Management’s SQZ Biotechnologies Company SQZ Stock Holding History

Baldrige Asset Management’s Portfolio SQZ Stock Details SQZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$3K	Hold	5,000	–	–	﹤0.01%	307
2022 Q4	$4K	Hold	5,000	–	–	﹤0.01%	278
2022 Q3	$11K	Hold	5,000	–	–	0.01%	245
2022 Q2	$16K	Hold	5,000	–	–	0.01%	230
2022 Q1	$24K	Hold	5,000	–	–	0.01%	221
2021 Q4	$45K	Hold	5,000	–	–	0.02%	176
2021 Q3	$72K	Sell	5,000 -447	-8%	-$6.06K	0.03%	146
2021 Q2	$79K	Buy	+5,447	New	+$71.2K	0.03%	141

Other funds holding SQZ

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baldrige Asset Management's SQZ Position: Q1 2023 in Review

Baldrige Asset Management held its SQZ Biotechnologies Company (SQZ) position steady in Q1 2023 at 5,000 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #307.

Baldrige Asset Management first reported a position in SQZ in Q2 2021 and has held it in 8 quarters since. The position peaked at $79K in Q2 2021. 32 funds tracked by Wall St. Rank hold SQZ as of Q1 2023.

Baldrige Asset Management held 5,000 shares of SQZ Biotechnologies Company worth $3K as of Q1 2023.
Baldrige Asset Management left its SQZ Biotechnologies Company share count unchanged in Q1 2023.
SQZ Biotechnologies Company made up ﹤0.01% of Baldrige Asset Management's portfolio in Q1 2023, its #307 holding.
Baldrige Asset Management first reported a position in SQZ Biotechnologies Company in Q2 2021 and has held it in 8 quarters since.
Baldrige Asset Management's SQZ Biotechnologies Company position peaked at $79K in Q2 2021.
32 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q1 2023.

Based on Baldrige Asset Management's 13F filing for Q1 2023, filed 17 Apr 2023.